Chapter 164, three black technologies under research

The shareholders' meeting was held on June 20 at the Miyamoto Twin Building in Chiyoda-ku, and a total of 30 consortium shareholders attended the meeting. As for the content of the meeting, Meidong has already been familiar with a lot in the past two months, and although there will still be new gains today, it is still mainly a formality.

It must be admitted that Miyamoto Pharmaceutical and Advanced Biotechnology ABT are indeed the core of the consortium. Because in the past period, Meidong has been paying attention to the heavy industry in Honshu, coupled with the insensitivity to the medical industry, so the attention to them is limited. But it turns out that they have the capital to make the owner of a family spend a lot of money to build a skyscraper in the heart of Tokyo.

If you want to say why, the projects that ABT leads the research and development here, whether they have been listed by Miyamoto Pharmaceutical or are under research, are too much of a black technology.

For example, the anti-cancer drugs that have been marketed, in fact, Meidong is very unable to understand the mysterious concept of drug efficacy, unless it really achieves the level of a divine elixir. Anyway, according to the shareholder, the company's anti-cancer drugs not only involve almost all known cancers, but also have a cure rate of more than 70% for the most common ones, and even for advanced patients, it can achieve 30%, which really sounds good.

Of course, the price is also very expensive, and the cost of the whole course of treatment for advanced lung cancer is so high that it can definitely bring an ordinary middle class with no debt to the brink of bankruptcy, and the cure rate is only 30%. But fortunately, one is that it is only on the verge of bankruptcy and not really bankrupt, and it is called advanced lung cancer.

Even in the case of AIDS, Miyamoto Pharmaceutical has ready-made products on the market. Although it is not enough to be completely cured, it is still possible to let the patient live to be over 60 years old if he or she can continue to take the medication on time and is not terminally ill at the time of the initial state. It's just the same thing, this is a huge expense, and although the consumption per unit of time is not comparable to curing cancer, it is still a huge amount in a lifetime.

As for the projects under research, Meidong can only say that it is no wonder that my grandfather chose to be listed in the United States, because the domestic one-third of an acre of land really can't provide such a big stage.

First of all, the expert that Mito had contacted a month ago, Takuya Tokugawa, led a new hybrid rice project.

It is important to know that even if China has become the world's largest grain importer for many years, let alone Japan, which has few land and many people. A high-quality square watermelon costs 60,000 yen, and four ping-pong ball-sized special organic tomatoes cost 8,000 yen, all of which are the prices of Japanese agricultural products. If his project is really successful, even if it only doubles the yield per acre, how much more revenue will this increase?

Because it is obvious that due to the high cost of Japanese agriculture and the support of the government, even if the output suddenly increases several times, its price will not change much, especially if Tokugawa's technology can be further expanded and applied to those large soccer watermelons priced at 60,000 yen each, I am afraid that farmers across the country will not cheer?

Then there is the research of controlled nuclear fusion, and when she heard this news, Midong was only slightly surprised, and did not mean to be shocked by the big teeth. You know, China and the United States have already developed mature tokmak devices, but the power is still very low and the volume is still very large, and it cannot be applied to power stations. Japan's private consortium must also be conducting research, after all, how much of the country's electricity is supplied by nuclear energy, how can there be a reason not to participate.

If you want to say that it is unexpected, it is that the Miyamoto Foundation is also carrying out this project, after all, its size is still not comparable to that of Mitsubishi and Sumitomo. Something like this, which has not responded to many years of dry investment, is also a loss to everyone who can stick to it.

And then there is the most important thing for Meidong, the reverse reduction project of petroleum products. Major oil companies around the world are working on the project, including PetroChina and Sinopec, BP and Mobil Oil, Dutch Shell and any other industry leader who can make a name for himself.

For example, in three years, many European countries will announce the suspension of gasoline cars, and in the context of tokmak devices being used to generate electricity sooner or later, if they do not quickly expand the industrial chain, they must die without a place to bury.

"Therefore, among the three projects, the investment in the reverse reduction project is the largest."

The shareholder said: "Because it is at least a project that can generate immediate benefits, there may be countless ways to generate electricity, but the current human industrial system is absolutely inseparable from the manufacture of goods from oil." I'm sure you know how many huge mountains of garbage there are in the United States, and as long as this technology reaches a certain level of maturity, those are all gold that can turn waste into treasure! ”

"So, our research center is here."

Midong nodded, and scanned the documents provided by the reporting shareholder.

At the southeastern tip of Tokyo, further south of Edogawa Ward, is the city of Urayasu next to Tokyo Bay. The area here is very small, only 17 square kilometers, if the Abang Palace is still built, it is difficult to barely plug it. The famous Tokyo Disneyland is located here, but if there is anything left, it seems that it is a group of old industrial staff dormitories?

And, of course, there are countless neatly arranged single-family houses.

The Miyamoto Foundation's Reverse Reduction Engineering Research Center is located at the southeastern tip of this small city. Sure enough, it is a huge industrial area, and there are many large warehouses, and there is even a direct name "Sumitomo Warehouse", indicating its belonging and significance.

The research center is one of the buildings here.

"Very well, since the distance is so close, let's go and inspect it later."

Meidong set the itinerary for the afternoon, and said to the shareholder: "Please answer me a question first, on this project, the company is currently unable to launch the finished product, is it because of the problem of conversion efficiency, or is it technically not up to par?" ”

"Conversion efficiency."

The shareholder replied, "If we can't even do the transformation itself, we won't have to let countries around the world start research and development, but efficiency is the biggest problem." If you look at it, you can see that unless we can make new breakthroughs in existing processes, we will have to rely on substances such as catalysts. Although some scholars have written relevant papers, ......"

"But Xinhai Curtissan is affiliated with Mitsubishi Chemical, you mean that."

Seeing the shareholder's surprised expression, Midong smiled softly.

"Now that I'm clear about these three areas, I'm asking you a related question."

At this moment, Mei Dong's eyes swept across the audience, staring at these old men who were at least forty years old.

"What about research in the field of pure biology? For example, we at Miyamoto Pharmaceutical should have many other laboratories around the world, right? ”